Quinidine and dihydroquinidine interactions in human plasma

Area of Science:

• Pharmacology
• Biochemistry
• Analytical Chemistry

Background:

• Quinidine is a widely used antiarrhythmic drug.
• Dihydroquinidine is a known impurity in pharmaceutical-grade quinidine.
• Understanding drug-impurity interactions in plasma is crucial for drug safety and efficacy.

Purpose of the Study:

• To investigate the protein-binding characteristics of dihydroquinidine in human plasma.
• To determine the effect of dihydroquinidine on quinidine's plasma protein binding.
• To assess the potential for competitive binding between dihydroquinidine and quinidine.

Main Methods:

• Equilibrium dialysis was employed to study protein binding.
• Plasma concentrations of dihydroquinidine and quinidine were analyzed.
• Association constants (K) and total binding site concentrations (nPt) were calculated.

Main Results:

• Dihydroquinidine exhibited binding similar to quinidine across tested plasma concentrations.
• Both compounds appeared to share a single class of binding sites.
• While low levels of dihydroquinidine had no significant effect, 20% dihydroquinidine increased unbound quinidine concentrations (p < 0.05).

Conclusions:

• Dihydroquinidine and quinidine competitively interact for binding sites on human plasma proteins.
• The observed increase in unbound quinidine at higher dihydroquinidine levels suggests potential clinical relevance.
• These findings highlight the importance of impurity profiling in drug quality control.